OPAL CALDWELL: Open Payments
NPI 1548784945 · MORRISTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,190 in 88 payments from 12 companies in 2025. Trend: 2023 $984 · 2024 $9,496 · 2025 $11,190
Speaker / faculty: $9,430Food & beverage: $1,115Travel & lodging: $645
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 37 | $10,426 |
| ABBVIE INC. | 13 | $178 |
| Gilead Sciences, Inc. | 17 | $141 |
| Madrigal Pharmaceuticals | 4 | $112 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $99 |
| Ardelyx, Inc. | 4 | $93 |
| Aimmune Therapeutics, Inc. | 2 | $37 |
| Lucid Diagnostics Inc. | 1 | $27 |
| EVOKE PHARMA, INC. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
Products named: VOQUEZNA, REZDIFFRA, MAVYRET, XIFAXAN, IBSRELA, CREON, ZENPEP, GIMOTI.
Industry payments across TN — which companies pay providers there.
